Beneficial effects of leukocyte-depleted blood and low-potassium dextran solutions on microvascular permeability in preserved porcine lung

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 2, 1999, Pages 689-697

  Schneuwly, Odile D ^a   Licker, Marc ^a   Pastor, Catherine M ^a   Schweizer, Alexandre ^a   Slosman, Daniel O ^a   Kapanci, Yusuf ^a   Nicod, Laurent P ^a   Robert, John ^a   Spiliopoulos, Anastase ^a   Morel, Denis R ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; EURO COLLINS SOLUTION;

ANIMAL TISSUE; ARTICLE; LEUKOCYTE; LUNG FUNCTION; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; SWINE;

EID: 0032814849     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.2.9809029     Document Type: Article

References (43)

1. 1. Davis, R. D., and M. K. Pasque. 1995. Pulmonary transplantation. Ann. Surg. 221:14-28.
2. 2. Kcenan, R. J., B. P. Griffith, R. L. Kormos, J. M. Armitage, and R. L. Hardesty. 1991. Increased perioperative lung preservation injury with lung procurement by Euro-Collins solution flush. J. Heart Lung Transplant. 10:650-655.
3. 3. Collins, G. M., M. Bravo-Shugarman, and P. I. Terasaki, 1969. Kidney preservation for transportation: initial perfusion and 30 hours' ice storage. Lancet 2:1219-1222.
4. 4. Keshavjec, S. H., F. Yamazaki, H. Yokomise, P. F. Cardoso, J. B. M. Mullen, A. S. Slutsky, and G. A. Patterson. 1992. The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation. J. Thorac, Cardiovasc. Surg. 103:314-325.
5. 5. Yamazaki, F., H. Yokomise, S. H. Keshavjec, S. Miyoshi, P. F. Cardoso, A. S. Slutsky, and G. A. Patterson. 1990. The superiority of an extracellular fluid solution over Euro-Collins' solution for pulmonary preservation. Transplantation 49:690-694.
6. 6. Binns, O. A. R., N. F. DeLima, S. A. Buchanan, J. T. Cope, R. C. King, C. A. Marek, K. S. Shockey, C. G. Tribble, and I. L. Kron. 1996. Both blood and crystalloid-based extracellular solultions are superior to intracellular solutions for lung preservation. J. Thorac. Cardiovasc. Surg. 112:1515-1521.
7. 7. Oka, T., J. D. Puskas, F., Mayer, P. F. G. Cardoso, S. Shi, W. Wisser, A. S. Slutsky, and G. A. Patterson. 1991. Low-potassium UW solution for lung preservation: comparison with regular UW, LPD, and Euro-Collins solutions. Transplantation 52:984-988.
8. 8. Xiong, L., M. Mazmanian, A. R. Chapelier, J. Reignier, M. Weiss, P. G. Dartevelle, and P. Hervé. 1994. Lung preservation with Euro-Collins. University of Wisconsin, Wallwork, and low-potassium-dextran solutions. Ann. Thorac. Surg. 58:845-850.
9. 9. Keshavjce, S. H., F. Yamazaki, P. F. Cardoso, D. I. McRitchie, G. A. Patterson, and J. D. Cooper. 1989. A method for safe twelve-hour pulmonary preservation. J. Thorac. Cardiovasc. Surg. 98:529-534.
10. 10. Sundaresan, S., O. Lima, H. Date, A. Matsumura, H. Tsuji, H. Obo, M. Aoe, T. Mizuta, and J. D. Cooper. 1993. Lung preservation with low-potassium dextran flush in a primate bilateral transplant model. Ann. Thorac. Surg. 56:1129-1135.
11. 11. DeLima, N. F., O. A. R. Binns, S. A. Buchanan, J. T. Cope, M. C. Mauney, K. S. Shockey, C. G. Tribble, and L. L. Kron. 1996. Low-potassium solution for lung preservation in the setting of high-flow reperfusion. Ann. Thorac. Surg. 61:973-976.
12. 12. Hakim, M., T. Higenbottam, D. Bethune, R. Coory-Pearce. T. A. H. English, J. Kneeshaw, F. C. Wells, and J. Wallwork. 1988. Selection and procurement of combined heart and lung grafts for transplantation. J. Thorac. Cardiovasc. Surg. 95:474-179.
13. 13. Gorin, A. B., W. J. Weidner, R. H. Demling, and N. C, Staub. 1978. Noninvasive measurement of pulmonary transvascular protein flux in sheep. J. Appl. Physiol. 45:225-233.
14. 14. Basran, G. S., A. J. Byrne, and J. G. Hardy. 1985. A noninvasive technique for monitoring lung vascular permeability in man. Nucl. Med. Commun. 6:3-10.
15. 15. Dauber, I. M., W. T. Pluss, A. VanGrondelle, R. S. Trow, and J. V. Weil. 1985. Specificity and sensitivity of noninvasive measurement of pulmonary vascular protein leak. J. Appl. Physiol. 59:504-574.
16. 16. Christie, N. A., D. E. Smith, K. N. Decampos, A. S. Slutsky, G. A. Patterson, and A. K. Tanswell. 1994. Lung oxidant injury in a model of lung storage and extended reperfusion. Am. J. Respir. Crit. Care Med. 150:1032-1037.
17. 17. Adkins, W. K., and A. E. Taylor. 1990. Role of xanthine oxidase and neutrophils in ischemia-reperfusion injury in rabbit lung. J. Appl Physiol. 69:2012-2018.
18. 18. Farrukh, I. S., J. R. Michael, S. P. Peters, A. M. Sciuto, N. F. Adkinson, H. S. Freeland, A. Paky, E. W. Spannhake, W. R. Summer, and G. H. Gurtner. 1988. The role of cyclooxygenase and lipoxygenase mediators in oxidant-indueed lung injury. Am. Rev. Respir. Dis. 137:1343-1349.
19. 19. Ljungman, A. G., C. M. Grum, G. M. Deeb, S. F. Boiling, and M. L. Morganroth. 1991. Inhibition of cyclooxygenase metabolite production attenuates ischemia-reperfusion lung injury. Am. Rev. Respir. Dis. 143:610-617.
20. 20. Okada, M., C. Yamashita, M. Okada, and K. Okada. 1995. Contribution of endothelin-1 to warm ischemia/reperfusion injury of the rat lung. Ant. J. Respir. Crit. Care Med. 152:2105-2110.
21. 21. Matthay, M. A., H. G. Folkesson, A. Campagna, and F. Kheradmand. 1993. Alveolar epithelial barrier and acute lung injury. New Horizons 1:613-622.
22. 22. Nilsson, F. N., C. G. A. McGregor, and V. M. Miller. 1992. Pulmonary arterial reactivity after transplantation: differential effects of denervation and rejection. J. Thorac. Cardiovasc. Surg. 103:751-762.
23. 23. Christie, N. A., and T. K. Waddell. 1993, Lung preservation. Chest Surg. Clin. N. Am. 3:29-46.
24. 24. Pinsky, D. J., Y. Naka, N. C. Chowdhury, H. Liao, M. C. Oz, R. E. Michler, E. Kubaszewski, T. Malinski, and D. M. Stern. 1994. The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation, Proc. Natl. Acad. Sci. U.S.A. 91:12086-12090.
25. 25. Maccherini, M., S. H. Keshavjee, A. S. Slutsky, G. A. Patterson, and J. D. Edelson. 1991. The effect of low-potassium-dextran versus Euro-Collins solution for preservation of isolated type II pneumocytes. Transplantation 52:621-626.
26. +-induced membrane depolarization. J. Cell Physiol. 166:274-280.
27. 27. Kimblad, P. O., T. Sjöberg, G. Massa, J.-A. Solem, and S. Steen. 1991. High potassium contents in organ preservation solutions cause strong pulmonary vasoconstriction. Ann. Thorac. Surg. 52:523-528.
28. 28. Tanaka, H., Y. Chiba, M. Sasaki, S. Matsukawa, and R. Muraoka. 1998. Relationship between flushing pressure and nitric oxide production in preserved lungs. Transplantation 65:460-464.
29. 29. Puskas, J. D., P. F. G. Cardoso. E. Mayer, S. Shi, A. S. Slutsky, and G. A. Patterson. 1992. Equivalent eighteen-hour lung preservation with low-potassium dextran or Euro-Collins solution after prostaglandin E1 infusion. J. Thorac. Cardiovasc. Surg. 104:83-89.
30. 30. Novick, R. J., K. R. Reid, L. Denning, J. Duplan, A. H. Menkis, and F. N. McKenzie. 1991. Prolonged preservation of canine lung allografts: the role of prostaglandins. Ann. Thorac. Surg. 51:853-859.
31. 31. Higgins, R. S. D., G. V. Letsou, J. A. Sanchez, R. N. Eisen, G. J. Walker Smith, K. L. Franco, G. L. Hammond, and J. C. Baldwin. 1993. Improved ultrastructural lung preservation with prostaglandin E1 as donor pretreatment in a primate model of heart lung transplantation. J. Thorac. Cardiovasc. Surg. 105:965-971.
32. 32. Hooper, T. L., D. S. Thomson, M. T. Jones, L. Cook, S. Owen, S. Wilkes, A. Woodcock, A. H. Webster, P. Hasleton, C. S. Campbell, A. N. Rahman, and C. G. A. McGregor. 1990. Amelioration of lung ischemic injury wilh prostacyclin. Transplantation 49:1031-1035.
33. 33. Barnard, J. W., A. F. Scibert, V. R. Prasad, D. A. Smart, S. J. Strada, A. E. Taylor, and W. J. Thompson. 1994. Reversal of pulmonary capillary ischemia-reperfusion injury by rolipram, a cAMP phosphodiesterase inhibitor. J. Appl. Physiol. 77:774-781.
34. 34. Chiang, C.-H., K, Hsu, H.-C. Yan, H.-J. Harn, and D.-M. Chang. 1997. PGE1, dexamethasone, U-74389G, or Bt2-cAMP as an additive to promote protection by UW solution in I/R injury. J. Appl. Physiol. 83:583-590.
35. 35. Okabayashi, K., M. Aoc, S. R. DeMcester, J. D. Cooper, and G. A. Patterson. 1994. Pentoxifylline reduces lung allograft reperfusion injury. Ann. Thorac. Surg. 58:50-56.
36. 36. Bhabra, M. S., D. N. Hopkinson, T. E. Shaw, and T. L. Hooper. 1996. Relative importance of prostaglandin/cyclic adenosinc monophosphate and nitric oxide/cyclic guanosine monophosphate pathways in lung preservation. Ann. Thorac. Surg. 62:1494-1499.
37. 37. Fujino, S., I. Nagahiro, M. Yamashita, M. Yano, R. A. Schmid, J. D. Cooper, and G. A. Patterson. 1997. Preharvest nitroprusside flush improves posttransplantation lung function. J. Heart Lung Transplant. 16: 1073-1080.
38. 38. Shiraishi, Y., J. Ryul Lee, H. Laks. P. F. Waters, A. Meneshian, A. Blitz, K. Johnson, L. Lam, and P. A. Chang. 1996. L-arginine administration during reperfusion improves pulmonary function. Ann. Thorac. Surg. 62:1580-1587.
39. 39. Sakamaki, F., H. Hoffmann, C. Müller, H. Dienemann, K. Messmer, and F. W. Schildberg. 1997. Reduced lipid peroxidation and ischemia-reperfusion injury after lung transplantation using low-potassium dextran solution for lung preservation. Am. J. Respir. Crit. Care Med. 156:1073-1081.
40. 40. Bergentz, S. E., and D. Bergqvist. 1984. Dextran in vascular surgery. Vasc. Surg. 18:51-56.
41. 41. Hamacher, J., S. Sadallah, J. A. Schifferli, J. Villard, and L. P, Nicod. 1998. Soluble complement receptor type 1 (CD35) in bronchoalveolar lavage in inflammatory lung diseases. Eur. Respir. J. 11:112-119.
42. 42. Pittet, J. F., R. C. Mackersic.T. R. Martin, and M. A. Matthay. 1997. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am. J. Respir. Crit. Care Med. 155:1187-1205.
43. 43. King, R. C., O. A. R. Binns, R. C. Kanithanon, P. E. Parrino, T. B. Reece, J. D. Maliszewskyj. K. S. Shockey, C. G. Tribble, and I. L. Kron. 1997. Acellular low-potassium dextran preserves pulmonary function after 48 hours of ischemia. Ann. Thorac. Surg. 64:795-800.